GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

The low-cost gym giant is coming off four consecutive months of higher foot traffic despite raising its signature membership price to $15 from $10 last summer. Galaxy Digital Sees Demand Surge as U.S.

GSK PLC closed 19.70% below its 52-week high of £16.79, which the company achieved on September 9th.

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...

Warren Buffett is one of the most renowned investors of our time. So, it’s easy to forget that he was once a beginner too.

Many people think that Warren Buffet is a good lead indicator for financial markets, and Berkshire Hathaway has been offloading US banks in recent months. Many people may ask why sell stocks when they ...

The Swedish defense company posted better-than-expected earnings and [raised its annual sales guidance]( ...

Arexvy is currently approved for use in all individuals aged 60 and older, as well as for high-risk individuals aged 50-59.

Investor sentiment in the restaurant sector is currently strongest for YUM! Brands and Shake Shack (NYSE: SHAK), according to ...